COVID-19 Impact and Recovery Analysis | Pharmaceutical Drug Development Services Procurement Intelligence Report Forecasts over USD 27 billion Spend Growth | SpendEdge
November 12, 2020LONDON–(BUSINESS WIRE)–#pharmaceuticaldrugdevelopmentservicesmarket–The global pharmaceutical drug development market is poised to experience spend growth of more than USD 27 billion between 2024 at a CAGR of over 9.34%. The report also provides the market impact and new opportunities created due to the COVID-19 pandemic. Request free sample pages.
Read the 120 pages research report with TOC and LOE on “The Global Pharmaceutical Drug Development Services Market – Procurement Intelligence Report, Pricing Outlook in Geographies that include APAC, North America, South America, and MEA, and insights into best practices to optimize procurement spend.”
SpendEdge’s reports now include an in-depth complimentary analysis of the COVID-19 impact on procurement and the latest market data to help your company overcome sourcing challenges. Our pharmaceutical drug development services procurement intelligence report offers actionable procurement intelligence insights, sourcing strategies, and action plans to mitigate risks arising out of the current pandemic situation. The insights offered by our reports will help procurement professionals streamline supply chain operations and gain insights in the best procurement practices to mitigate losses.
Information on Latest Trends and Supply Chain Market Information: Knowledge center on COVID-19 impact assessment
Insights into the Market Price Trends
- Raw material prices account for a significant portion of suppliers’ OPEX. Any increase in these prices leads to a substantial increase in suppliers’ OPEX which will have a direct impact on buyers Pharmaceutical Drug Development Services procurement price.
- The increase in minimum wages across countries and expectations for a better lifestyle will compel suppliers to increase their compensations for employees. While this will increase suppliers’ OPEX, this will have an inflationary impact on buyers’ pharmaceutical drug development services procurement expenditure.
Insights into strategies that will help buyers optimize their procurement spend
- This will aid buyers to optimize their pharmaceutical drug development services procurement budget.
- This will aid buyers to minimize their expenditure on pharmaceutical drug development services procurement.
To get instant access to over 1000 market-ready procurement intelligence reports without any additional costs or commitment Subscribe Now for Free.
Some of the top Pharmaceutical Drug Development Services suppliers enlisted in this report
This pharmaceutical drug development services procurement intelligence report has enlisted the top suppliers and their cost structures, SLA terms, best selection criteria, and negotiation strategies.
- IQVIA Holdings Inc.
- Laboratory Corp. of America Holdings
- PAREXEL International Corp.
- ICON Plc
- Syneos Health Inc.
- PPD Inc.
- PRA Health Sciences Inc.
- Charles River Laboratories International Inc.
- WuXi AppTec Co. Ltd.
- Medpace Holdings Inc.
Get access to regular sourcing and procurement insights to our digital procurement platform- Activate Free subscription.
Table of Content
Executive Summary
Market Insights
Category Pricing Insights
Cost-saving Opportunities
Best Practices
Category Ecosystem
Category Management Strategy
Category Management Enablers
Suppliers Selection
Suppliers under Coverage
US Market Insights
Category scope
Appendix
About SpendEdge:
SpendEdge shares your passion for driving sourcing and procurement excellence. We are the preferred procurement market intelligence partner for 120+ Fortune 500 firms and other leading companies across numerous industries. Our strength lies in delivering robust, real-time procurement market intelligence reports and solutions. To know more, https://www.spendedge.com/request-for-demo?
Contacts
SpendEdge
Anirban Choudhury
Marketing Manager
US: +1 630 984 7340
UK: +44 148 459 9299
https://www.spendedge.com/contact-us